1 |
Onozawa, M., Fukuda, K., Ohtani, M., Akaza, H., Sugimura, T. and Wakabayashi, K. : Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP. Jpn. J. Clin. Oncol. 28, 360 (1998).
DOI
ScienceOn
|
2 |
Delhalle, S., Duvoix, A., Schnekenburger, M., Morceau, F., Dicato, M. and Diederich, M. : An introduction to the molecular mechanisms of apoptosis. Ann. N. Y. Acad. Sci. 1010, 1 (2003).
DOI
|
3 |
Hong, S. J., Dawson, T. M. and Dawson, V. L. : Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol. Sci. 25, 259 (2004).
DOI
ScienceOn
|
4 |
Prez-Roger, I., Ivorra, C., Dez, A., Corts, M. J., Poch, E., Sanz- Gonzlez, S. M. and Andrs, V. : Inhibition of cellular proliferation by drug targeting of cyclin-dependent kinases. Curr. Pharm. Biotechnol. 1, 107 (2000).
DOI
|
5 |
O'Connor, P. M. and Kohn, K. W. : A fundamental role for cell cycle regulation in the chemosensitivity of cancer cells? Semin. Cancer Biol. 3, 409 (1992).
|
6 |
Zhou, J. R., Mukherjee, P., Gugger, E. T., Tanaka, T., Blackburn, G. L. and Clinton, S. K. : Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis. Cancer Res. 58, 5231 (1998).
|
7 |
Hickman, J. A. : Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11, 121 (1992).
DOI
ScienceOn
|
8 |
El-Kenawi, A. E. and El-Remessy, A. B. : Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales. Br. J. Pharmacol. 170, 712 (2013).
DOI
|
9 |
Qu, Z., MacLellan, W. R. and Weiss, J. N. : Dynamics of the cell cycle: checkpoints, sizers, and timers. Biophys. J. 85, 3600 (2003).
DOI
ScienceOn
|
10 |
Pines, J. : Cyclins and cyclin-dependent kinases: a biochemical view. Biochem. J. 308, 697 (1995).
DOI
|
11 |
Hickman, J. A. : Apoptosis induced by anticancer drugs. Cancer Metastasis Rev. 11, 121 (1992).
DOI
ScienceOn
|
12 |
Jin, S., Zhang, Q. Y., Kang, X. M., Wang, J. X. and Zhao, W. H. : Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann. Oncol. 21, 263 (2010).
DOI
|
13 |
Choi, E. J. and Kim, G. H. : Daidzein causes cell cycle arrest at the G1 and G2/M phases in human breast cancer MCF-7 and MDA-MB-453 cells. Phytomedicine 15, 683 (2008).
DOI
ScienceOn
|
14 |
Sergeev, I. N. : Genistein induces Ca2+ -mediated, calpain/ caspase-12-dependent apoptosis in breast cancer cells. Biochem. Biophys. Res. Commun. 321, 462 (2004).
DOI
|
15 |
Li, Z., Li, J., Mo, B., Hu, C., Liu, H., Qi, H., Wang, X. and Xu, J. : Genistein induces cell apoptosis in MDA-MB-231 breast cancer cells via the mitogen-activated protein kinase pathway. Toxicol. In Vitro 22, 1749 (2008).
DOI
|
16 |
Zheng, J., Jin, Y. and Row, K. H. : Analysis of isoflavones from Korean and Chinese soybean and processed products by HPLC. J. Korean Chem. Society 49, 349 (2005).
DOI
|
17 |
Choi, Y. H., Lim, H., Heo, M. Y., Kwon, D. Y. and Kim, H. P. : Anti-inflammatory activity of the ethanol extract of Chungkukjang, Korean fermented bean: 5-lipoxygenase inhibition. J. Med. Food 11, 539 (2008).
DOI
ScienceOn
|
18 |
Kim, N. Y., Song, E. J., Kwon, D. Y., Kim, H. P. and Heo, M. Y. : Antioxidant and antigenotoxic activities of Korean fermented soybean. Food Chem. Toxicol. 46, 1184 (2008).
DOI
ScienceOn
|
19 |
Wada, K., Nakamura, K., Tamai, Y., Tsuji, M., Kawachi, T., Hori, A., Takeyama, N., Tanabashi, S., Matsushita, S., Tokimitsu, N. and Nagata, C. : Soy isoflavone intake and breast cancer risk in Japan: from the Takayama study. Int. J. Cancer 13, 952 (2013).
|
20 |
Hwang, J. S., Yoo, H. J., Song, H. J., Kim, K. K., Chun, Y. J., Matsui, T. and Kim, H. B. : Inflammation-related signaling pathways implicating TGF are revealed in the expression profiling of MCF7 cell treated with fermented soybean, chungkookjang. Nutr. Cancer 63, 645 (2011).
DOI
ScienceOn
|
21 |
Nagata, C. : Factors to consider in the association between soy isoflavone intake and breast cancer risk. J. Epidemiol. 20, 83 (2010).
DOI
|
22 |
Messina, M. J., Persky, V., Setchell, K. D. and Barnes, S. : Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 21, 133 (1994).
DOI
ScienceOn
|
23 |
Messina, M. and Messina, V. : Increasing use of soyfoods and their potential role in cancer prevention. J. Am. Diet Assoc. 91, 836 (1991).
|
24 |
Molteni, A., Brizio-Molteni, L. and Persky, V. : In vitro hormonal effects of soybean isoflavones. J. Nutr. 125, 751S (1995).
|
25 |
Kennedy, A. R. : The evidence for soybean products as cancer preventive agents. J. Nutr. 125, 733S (1995).
|
26 |
Knight, D. C. and Eden, J. A. : A review of the clinical effects of phytoestrogens. Obstet. Gynecol. 87, 897 (1996).
|
27 |
Kurzer, M. S. and Xu, X. : Dietary phytoestrogens. Annu. Rev. Nutr. 17, 353 (1997).
DOI
ScienceOn
|
28 |
Kim, N. Y., Song, E. J., Kwon, D. Y., Kim, H. P. and Heo, M. Y. : Antioxidant and antigenotoxic activities of Korean fermented soybean. Food Chem. Toxicol. 46, 1184 (2008).
DOI
ScienceOn
|
29 |
Lewis, C. : A review of the use of chemoprotectants in cancer chemotherapy. Drug Saf. 11, 153 (1994).
DOI
|
30 |
Kao, T. H., Wu, W. M., Hung, C. F., Wu, W. B. and Chen, B. H. : Anti-inflammatory effects of isoflavone powder produced from soybean cake. J. Agric. Food Chem. 55, 11068 (2007).
DOI
ScienceOn
|
31 |
Gottesman, M. M. : Report of a meeting: molecular basis of cancer therapy. J. Natl. Cancer Inst. 86, 1277 (1994).
DOI
|